Company Filing History:
Years Active: 2024
Title: Michelle Higgins: Innovator in Nucleic Acid Technology
Introduction
Michelle Higgins is a prominent inventor based in Carlsbad, CA (US). She has made significant contributions to the field of nucleic acid technology, particularly in the area of sample capture and purification. Her innovative work has the potential to enhance various applications in biological research and diagnostics.
Latest Patents
Michelle Higgins holds a patent for a groundbreaking invention titled "Nucleic acid capture, concentration, and purification." This patent describes a kit that includes a flow cell assembly. The flow cell assembly features a reaction chamber, a temperature-controlled flow channel in selective fluid communication with an inlet of the reaction chamber, and a filter positioned in the temperature-controlled flow channel. The reaction chamber contains depressions separated by interstitial regions, with capture primers attached within each of the depressions. The filter is designed to block concentrated biological sample-polymer complexes generated in the temperature-controlled flow channel at a first temperature, while allowing the passage of concentrated biological sample and polymer released from the complexes in the temperature-controlled flow channel at a second temperature. This innovative approach has the potential to streamline nucleic acid processing.
Career Highlights
Michelle Higgins is currently employed at Illumina Corporation, a leading company in the field of genomics. Her work at Illumina has allowed her to collaborate with other talented professionals in the industry.
Collaborations
Some of her notable coworkers include Sean M. Ramirez and Anmiv Prabhu. Their collective expertise contributes to the advancement of innovative technologies in the field.
Conclusion
Michelle Higgins is a remarkable inventor whose work in nucleic acid technology is paving the way for advancements in biological research. Her patent demonstrates her commitment to innovation and her contributions to the scientific community are invaluable.